Is Certara, Inc. (CERT) a Buy, Sell, or Hold?
NASDAQ : CERT
Certara, Inc.
$6.93 USD
-$0.35 (-4.81%)
- Volume
- 2.11M
- Average Volume
- 4.08M
- Market Capitalization
- $1.08B
- P/E Ratio
- -72.49
- Dividend Yield
- 0.00%
- Price Target
- $9.00
- Year High
- $13.88
- Year Low
- $4.45
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.88
Company Overview
NASDAQ
Jon Resnick
Medical - Healthcare Information Services
Healthcare
CERT
1576
US
USD
Liquidity Metrics
0.30
1.88
1.88
1.04
0.00
Sales & Valuation
$418.84M
2.57
1.07
13.01
0.53
Profitability
-$0.01
-$1.6M
-3.60%
-1.16%
-1.43%
-1.01%
P/E Metrics
-72.49
-0.11
-0.11
Analyst Price Target & Rating
$9.00
$10.00
$8.00
2/5
16 Analysts
-23.00%
Poll Results
About Certara, Inc. (NASDAQ:CERT) Stock
Certara, Inc. provides advanced software solutions and technology-driven services, specializing in biosimulation throughout the entire drug development lifecycle. From initial drug discovery and preclinical research to clinical trials, regulatory submissions, and market entry, the company's core mission is to accelerate the delivery of new medicines to patients by transforming these processes with its innovative biosimulation software and expertise. Its extensive portfolio of technology-enabled services includes mechanistic and empirical biosimulation, strategic guidance for drug development and regulatory affairs, clinical pharmacology, model-based meta-analysis, specialized regulatory writing and medical communications, regulatory operations support, and market access consultation. Furth ... ermore, Certara offers a robust suite of software platforms covering mechanistic and empirical PK/PD biosimulation, data standardization and compliance, scientific informatics, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions, and market access communication. The company's clientele primarily comprises biopharmaceutical firms, academic institutions, and governmental organizations. Established in 2008 and headquartered in Princeton, New Jersey, Certara maintains a significant global presence, with operations spanning numerous countries including the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China.
2026-07-16 10:00:00
NEW YORK, July 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Certara, Inc. ("Certara" or the "Company") (NASDAQ: CERT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026
2026-07-15 16:15:00
RADNOR, Pa., July 15, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2026 before market open on Tuesday, August 4th, 2026. Company management will host a conference call to discuss financial results at 8:30AM ET.
2026-07-14 18:26:00
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Certara, Inc. (“Certara” or the “Company”) (NASDAQ: CERT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
2026-07-09 17:39:00
NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Certara, Inc. ("Certara" or the "Company") (NASDAQ: CERT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
2026-07-07 17:47:00
NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Certara, Inc. (“Certara” or the “Company”) (NASDAQ: CERT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Certara, Silo Pharma Advance AI Agent Strategies with Nvidia Initiatives
2026-07-07 14:18:56
NVIDIA Corp. (NASDAQ:NVDA) expanded its presence in life sciences AI through separate initiatives with Certara Inc. (NASDAQ:CERT) and Silo Pharma Inc. (NASDAQ:SILO).
Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit
2026-07-07 08:00:00
RADNOR, Pa., July 07, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, is partnering with NVIDIA to advance Certara's open integrated AI platform, unifying its scientific software, regulatory expertise, and proprietary datasets with AI-first, agentic frameworks.
2026-06-30 17:01:00
NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Certara, Inc. (“Certara” or the “Company”) (NASDAQ: CERT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Frequently Asked Questions
-
What is the current Certara, Inc. (CERT) stock price?
-
Certara, Inc.(NASDAQ:CERT) stock price is $6.93 in the last trading session. During the trading session, CERT stock reached the peak price of $13.88 while $4.45 was the lowest point it dropped to. The percentage change in CERT stock occurred in the recent session was --4.81% while the dollar amount for the price change in CERT stock was -$0.35.
-
CERT's industry and sector of operation?
-
The NASDAQ listed CERT is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector.
-
Who are the executives of CERT?
-
Leif E. Pedersen | President & Chief Commercial Officer
Robert Aspbury | President of Certara Predictive Technologies
Rona Anhalt | Chief Human Resources Officer
Sheila Rocchio | Chief Marketing Officer
Martin Snyder | President of Certara Data Sciences -
How many employees does CERT have?
-
Number of CERT employees currently stands at 1576. CERT operates from 4 Radnor Corporate Center, Radnor, PA 08540, US.
-
Link for CERT official website?
-
Official Website of CERT is: https://www.certara.com
-
How do I contact CERT?
-
CERT could be contacted at phone #609 716 7900 and can also be accessed through its website. CERT operates from 4 Radnor Corporate Center, Radnor, PA 08540, US.
-
How many shares of CERT are traded daily?
-
The average number of CERT shares traded daily for last 3 months was 4.08M.
-
What is the market cap of CERT currently?
-
The market value of CERT currently stands at $1.08B with its latest stock price at $6.93